4
Changes in Ownership
Altimmune, Inc. Filed Acc 0001104659-22-077433
Chief Scientific Officer sold 37,164 shares at $12.00 ($445,968)
- Chief Scientific Officer acquired 27,769 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Roberts M Scot Chief Scientific Officer | 2022-07-01 | Option exercise | +4,019 | $2.60 | $10,449 | 21,719 | D |
| Roberts M Scot Chief Scientific Officer | 2022-07-01 | Option exercise | +22,963 | $2.95 | $67,741 | 44,682 | D |
| Roberts M Scot Chief Scientific Officer | 2022-07-01 | Sale | −26,982 | $12.00 | $323,784 | 17,700 | D |
| Roberts M Scot Chief Scientific Officer | 2022-07-05 | Option exercise | +787 | $2.95 | $2,322 | 18,487 | D |
| Roberts M Scot Chief Scientific Officer | 2022-07-05 | Sale | −10,182 | $12.00 | $122,184 | 8,305 | D |
| Derivatives | |||||||
| Roberts M Scot Chief Scientific Officer | 2022-07-01 | Option exercise · Stock Options (option to buy) | −4,019 | 8,750 | D | ||
| Roberts M Scot Chief Scientific Officer | 2022-07-01 | Option exercise · Stock Options (option to buy) | −22,963 | 15,037 | D | ||
| Roberts M Scot Chief Scientific Officer | 2022-07-05 | Option exercise · Stock Options (option to buy) | −787 | 14,250 | D | ||
| Open-market sales · 37,164 sh · avg $12.00 · $445,968 | |||||||
Loading xslF345X03/tm2220386-1_4seq1.xml…